X-68838684-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004429.5(EFNB1):c.196C>T(p.Arg66*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004429.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not provided Pathogenic:4
This sequence change creates a premature translational stop signal (p.Arg66*) in the EFNB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EFNB1 are known to be pathogenic (PMID: 15959873, 16685650). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with craniofrontonasal syndrome (PMID: 15166289, 15959873, 16685650, 18627045, 23335590, 26586496). ClinVar contains an entry for this variant (Variation ID: 11715). For these reasons, this variant has been classified as Pathogenic. -
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20565770, 26586496, 23335590, 15166289, 18627045, 15959873, 16685650, 31618753) -
- -
- -
Craniofrontonasal syndrome Pathogenic:2
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at